The requirement for TIA1 in the pathophysiology of tauopathy was demonstrated by recent findings that TIA1 reduction prolongs lifespan and provides neuroprotection in the PS19 P301S tau mouse model, in a manner that reduced oligomeric tau but increased fibrillary tau [2]. Here, MAPT is linked to tauopathy.